Tue.Jan 07, 2025

article thumbnail

Simultaneous COVID-19, Influenza Vaccines Comparable with Sequential Immunization

Drug Topics

Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.

Vaccines 527
article thumbnail

FDA issues first recommendations on AI for drug development

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.

FDA 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Severe Case Results in First US Bird Flu Death

Drug Topics

The individual who first reported severe bird flu and hospitalization has since succumbed to their illness.

Hospitals 466
article thumbnail

STAT+: Generic GLP-1 drugs could help Medicare drive a harder bargain for Ozempic and Wegovy

STAT

The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide , according to experts familiar with the price-negotiation program and STAT’s review of documents from the first round of negotiations.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pharmacy Students Increasingly View Profession More Positively

Drug Topics

David Nau, PhD, discusses how more graduating pharmacy students say they would choose pharmacy again if starting college over.

307
307
article thumbnail

STAT+: Pharmalittle: We’re reading about FDA guidance on AI, meds releasing ‘forever chemicals,’ and more

STAT

Top of the morning to you, and a fine one it is, although we concede this may depend on your tolerance for frigid temperatures. Nonetheless, blue skies and a shiny sun are enveloping the Pharmalot campus, where the official mascots are hunting wildlife and we are engaged in the usual rituals — firing up the coffee kettle in order to brew a cup of stimulation (the choice today, hazelnut mocha) and foraging for items of interest.

FDA 101

More Trending

article thumbnail

PharmaVoice’s Crystal Ball: The industry’s AI future

PharmaVoice

How AI will further transform the business of drug discovery and development in 2025.

202
202
article thumbnail

FDA Requires Warning for Guillain-Barré Syndrome in Prescribing Information for RSV Vaccines

Pharmacy Times

Despite these concerns, experts have emphasized that the benefits of RSV vaccination outweigh potential risks for older adults, who are at heightened risk of severe RSV-related illness.

Vaccines 139
article thumbnail

Subcutaneous options offer convenience for patients — and a valuable window for drugmakers

PharmaVoice

New formulations for under-the-skin application of drugs give pharmas another opening in a crowded market.

147
147
article thumbnail

Rise of RSV Infections Is Associated With a Decrease of Vaccine Hesitancy

Pharmacy Times

Approximately 61% of individuals said respiratory syncytial virus (RSV vaccination for adults 60 years and older is effective.

Vaccines 139
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

How GenAI will transform life sciences in 2025

pharmaphorum

The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI).

121
121
article thumbnail

Association Found Between Diabetes and Excessive Daytime Sleepiness

Pharmacy Times

Age, frequent snoring, hypertension, and poor glycemic control are associated with excessive daytime sleepiness.

139
139
article thumbnail

FDA issues first guidance on AI in medicine development

pharmaphorum

The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area

FDA 116
article thumbnail

Coffee and Tea Linked to Lower Risk of Head and Neck Cancers

Pharmacy Times

A pooled analysis showed regular consumption of coffee and tea was associated with decreased risk of certain cancers.

132
132
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

One year after announcing a new maternal health model for women in Medicaid, the Centers for Medicare & Medicaid Services announced the participating states.

115
115
article thumbnail

The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AI

Pharmacy Times

AI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.

123
123
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Sanford Health finalized its merger with Marshfield Clinic Health System, the health systems announced last week, and the deal expands Sanford's reach to communities in Wisconsin and Michigans Upper Peninsula.

108
108
article thumbnail

Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict

The Guardian - Pharmaceutical Industry

Medical advances make pills to treat Alzheimers disease viable, though challenges remain in sharing gains globally Pills that prevent Alzheimers disease or blunt its effects are on the horizon, as the fight against dementia enters a new era, experts have said. Scientific advances were on the cusp of producing medicines that could be used even in the most remote and under-resourced parts of the world, thereby democratising care, said Jeff Cummings, professor of brain science and health at the Uni

108
108
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Verona says COPD drug is off to a flying start

pharmaphorum

Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.

105
105
article thumbnail

New study: Entities that don’t make medicines get half of what is spent on those medicines

PhRMA

Half of every dollar spent on brand medicines goes to entities that play no role in the research, development, or manufacturing of those medicines, according to a new analysis by Berkeley Research Group (BRG).

100
100
article thumbnail

US reports its first fatal case of H5N1 bird flu

pharmaphorum

A man in Louisiana has become the first recorded fatality in the US attributed to the H5N1 strain of bird flu.

105
105
article thumbnail

Denali Therapeutics’ ALS drug fails to improve function and survival in phase 2/3 trial

Outsourcing Pharma

Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future analysis.

94
article thumbnail

GSK bags breakthrough status for bone cancer drug

pharmaphorum

GSK has claimed its second breakthrough designation from the FDA for B7-H3-targeted ADC, this time in osteosarcoma.

FDA 105
article thumbnail

Building a Voice for Psychedelic Research

Pharmaceutical Commerce

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), explains why this resource is an asset, specifically for research in the psychedelic space.

94
article thumbnail

The great ISO IDMP implementation challenge: Are companies finally ready?

pharmaphorum

Large pharma companies now generally have good awareness of the value of IDMP-based product data standardisation as part of wider process digitalisation ambitions.

95
article thumbnail

Can you take DayQuil with amoxicillin?

The Checkup by Singlecare

Stricken with a sinus or ear infection, being treated with the antibiotic amoxicillin, and wondering what can be done for your nasal congestion, cough, and pain while you are waiting for the antibiotic to work? If this sounds familiar, you are not alone. Amoxicillin is a commonly called upon drug from the penicillin family, but it takes time for it to clear an infection.

article thumbnail

3 ways AI and patient-centred support can improve medication adherence

pharmaphorum

3 ways AI and patient-centred support can improve medication adherence Nicole.

94
article thumbnail

Structural Inequalities Contribute to Changes in Brain Structure and Connectivity

Pharmacy Times

These inequalities, which can include socioeconomic disparities, show neurological changes associated with aging and dementia.

81
article thumbnail

7 health benefits of oatmeal

The Checkup by Singlecare

A staple in American pantries, oats have been around for tens of thousands of years. The oat is a species of cereal grain native to parts of Asia and Europe, though dozens of countries worldwide grow and distribute oats today. While there are many ways to use oats, none are as popular as a warm, hearty bowl of oatmeal or porridge. Oatmeal is a cost-effective, accessible, and versatile breakfast option.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Twentyeight Health, a digital-first womens healthcare provider, picked up $10 million in series A funding and inked new payer partnerships with Medicaid insurers Aetna, AmeriHealth Caritas and Molina Healthcare.

article thumbnail

Fear of COVID-19 Among Post-Infected Adults Can Impact Quality of Life

Pharmacy Times

COVID-19 survivors deemed the most highly impacted and fearful also reported the lowest health-related quality of life scores, indicating an association.

73
article thumbnail

Variant Bio and Novo Nordisk to identify targets for metabolic disease treatment

Pharmaceutical Technology

Variant has entered a multi-year research partnership with Novo Nordisk to identify new targets to treat metabolic conditions.

69
article thumbnail

Camber Pharmaceuticals Announces Addition of Bortezomib for Injection

Pharmacy Times

Bortezomib for Injection is a proteasome inhibitor indicated for treatment of adult patients with multiple myeloma and treatment of adult patients with mantle cell lymphoma.

65